Dynocardia is addressing a 100-year-old challenge and an unmet need for accurate and continuous non-invasive blood pressure (cNIBP). ViTrack™ is the first cuff-less, wrist-wearable technology to offer accurate beat-to-beat measurement of BP with the accuracy of intra-arterial lines. Powered by a proprietary method to measure BP, ViTrack also provides continuous and accurate measures of heart rate, respiratory rate, and other cardio-hemodynamic parameters.
Dynocardia was founded by a team of engineers and physicians at MIT and Tufts Medical School, who had developed the technology with support from NIH. Dynocardia is laying the groundwork for entry into the hospital critical care market segment. As a part of this effort, the company is deploying the technology in various hospital care settings to collect clinical data.